These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1102901)

  • 41. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dosage isosorbide dinitrate therapy for angina.
    Tremblay G; Biron P; Désourdy F
    Can Med Assoc J; 1983 Mar; 128(6):679-81. PubMed ID: 6825033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
    Vázquez de Prada JA; Ruano J; Zueco J; Colman T; González-Vílchez F; Pajarón A
    Rev Esp Cardiol; 1989 Oct; 42(8):513-8. PubMed ID: 2602607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of isosorbide dinitrate and nitroglycerin in patients with angina pectoris].
    Zikmund M; Mayer O; Cepelák V
    Vnitr Lek; 1984 Nov; 30(11):1060-5. PubMed ID: 6440352
    [No Abstract]   [Full Text] [Related]  

  • 45. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

  • 46. [Living quality change of sini decoction in treating angina pectoris].
    Qin J; Wu W; Zhang J; Jin M; Wu G; Liu H
    Zhong Yao Cai; 2004 May; 27(5):385-7. PubMed ID: 15376397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
    [No Abstract]   [Full Text] [Related]  

  • 48. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 49. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A sequential trial of isosorbide dinitrate ("sorbitrate") in angina pectoris.
    Gulati RB; Mutalik GS
    Indian Pract; 1966 Mar; 19(3):245-8. PubMed ID: 5909513
    [No Abstract]   [Full Text] [Related]  

  • 51. Pindolol (Visken) and angina pectoris: a double blind multicentre trial.
    Thorpe P
    N Z Med J; 1972 Sep; 76(484):171-3. PubMed ID: 4564998
    [No Abstract]   [Full Text] [Related]  

  • 52. [Isosorbide dinitrate in exercise induced angina pectoris despite use of beta-blocking treatment. Clinical and hematological effects assessed by isotope angiocardiography].
    Jensen G; Trautner F; Rasmussen S; Hesse B
    Ugeskr Laeger; 1982 Nov; 144(44):3247-50. PubMed ID: 6761921
    [No Abstract]   [Full Text] [Related]  

  • 53. [Determination of the effect of a new anti-anginal drug, isosorbide dinitrate tape (TY0081), by Holter electrocardiography].
    Kohya T; Itoh K; Ando J; Tomita K; Yasuda H
    Kokyu To Junkan; 1983 Feb; 31(2):181-7. PubMed ID: 6867483
    [No Abstract]   [Full Text] [Related]  

  • 54. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
    Ganeshan KP; Xavier KB
    Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antianginal effect of transdermal isosorbide dinitrate (multicenter study)].
    Kékes E
    Orv Hetil; 1994 Oct; 135(44):2421-3. PubMed ID: 7970662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment.
    Schneider W; Bussmann WD; Stahl B; Wietschoreck A; Kaltenbach M
    Z Kardiol; 1985; 74 Suppl 1():55-63. PubMed ID: 3922143
    [No Abstract]   [Full Text] [Related]  

  • 57. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 58. [Continuous infusion of isosorbide dinitrate in intractable rest angina pectoris: report of a case].
    Fujii K; Tauchi M; Hoshida S; Kagiya T; Ozaki H; Mishima M; Kitabatake A; Inoue M; Kamata T
    J Cardiol Suppl; 1989; 22():17-9. PubMed ID: 2640861
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical effects of a sustained-release preparation of isosorbide dinitrate on angina pectoris.
    Arakawa K; Fujino M
    Clin Ther; 1980; 3(2):103-16. PubMed ID: 6778614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Long-term study with Stenoptin in general practice].
    Kessler H
    Med Welt; 1980 Jan; 31(4):149-51. PubMed ID: 6154224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.